FDA advises of updated Trasylol labelling

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2007年 / 1133卷 / 1期

关键词：

Blood Transfusion; Operative Setting; Coronary Artery Bypass Grafting; Artery Bypass; Renal Dysfunction;

D O I：

10.2165/00128415-200711330-00002

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[1] FDA advises caution for Trasylol
[J]. Reactions Weekly, 2006, 1122 (1) : 3 - 3
[2] Updated FDA labelling recommendations for biosimilars
[J]. Reactions Weekly, 2023, 1981 (1) : 6 - 6
[3] FDA advises on emergency contraception
Barnett, AA
[J]. LANCET, 1996, 348 (9019): : 53 - 53
[4] Bayer revises Trasylol labelling, admits undisclosure
[J]. Reactions Weekly, 2006, 1122 (1) : 2 - 2
[5] Genentech advises of US labelling change for Avastin
[J]. Reactions Weekly, 2005, 1036 (1) : 2 - 2
[6] US FDA advises caution for recombinant erythropoietins
[J]. Reactions Weekly, 2006, 1129 (1) : 2 - 2
[7] FDA advises against vapotherm respiratory device
Porterfield, AM
[J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (02) : 308 - 308
[8] FDA advises against needleless flu vaccinations
Riedmann, Eva M.
[J]. HUMAN VACCINES, 2011, 7 (12): : 1247 - 1247
[9] Amgen advises of US labelling change for darbepoetin alfa
[J]. Reactions Weekly, 2005, 1035 (1) : 2 - 2
[10] FDA Advises Safety Assessment of Food Nanomaterials
Cheeseman, Mitchell
[J]. FOOD TECHNOLOGY, 2012, 66 (08) : 152 - 152

← 1 2 3 4 5 →